TapewireFind a company

person · Reporting owner

Schlanger David J

Disclosed activity across 1 company

Tapewire entity
70264
SEC CIK
0001576145

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Progyny, Inc.PGNY · Entity 4521Director · Executive ChairmanJanuary 02, 2026January 05, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Progyny, Inc.

Report date January 02, 2026 · Filed January 05, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect238,462 Reported balance After 2026-01-02 transaction · row 1
1 source row

Row 1 · 2026-01-02 · Tax withholding · Disposed 2,171 · Balance 238,462

F1: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person.

Filing footnotes · ownership attribution and instrument terms

F1: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
February 01, 2021 Filed Feb 4, 2021 00:30 UTC Progyny, Inc. PGNY · Entity 4521 Exercise / conversionEmployee Stock Option (right to buy) · Derivative 50,000 $0.00 Strike: $0.91 $0.00
Disclosure

SEC source: 0001209191-21-007530 · doc4.xml · derivative · entry 13

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,684,384

Underlying: Common Stock · 50,000 shares

Expires 2027-08-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F11 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on January 16, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.

Read SEC document
February 01, 2021 Filed Feb 4, 2021 00:30 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 23,681 $48.36 $1,145,213.16
Disclosure

SEC source: 0001209191-21-007530 · doc4.xml · nonDerivative · entry 3

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2020.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.94 to $48.80 inclusive.

Read SEC document
February 01, 2021 Filed Feb 4, 2021 00:30 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 26,319 $47.53 $1,250,942.07
Disclosure

SEC source: 0001209191-21-007530 · doc4.xml · nonDerivative · entry 2

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,681

F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.94 to $47.93 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), (8) and (9).

Read SEC document
February 01, 2021 Filed Feb 4, 2021 00:30 UTC Progyny, Inc. PGNY · Entity 4521 Exercise / conversionCommon Stock 50,000 $0.91 $45,500.00
Disclosure

SEC source: 0001209191-21-007530 · doc4.xml · nonDerivative · entry 1

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 06, 2021 Filed Jan 7, 2021 01:07 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 13,206 $43.55 $575,121.30
Disclosure

SEC source: 0001209191-21-002386 · doc4.xml · nonDerivative · entry 6

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 12, 2020.

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.16 to $44.12 inclusive.

F3 · ownership.nature: The reportable securities are held directly by the David J. Schlanger 2020 SD LLC.

Read SEC document
January 06, 2021 Filed Jan 7, 2021 01:07 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 6,804 $42.79 $291,143.16
Disclosure

SEC source: 0001209191-21-002386 · doc4.xml · nonDerivative · entry 5

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 13,206

F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 12, 2020.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.16 to $43.15 inclusive.

F3 · ownership.nature: The reportable securities are held directly by the David J. Schlanger 2020 SD LLC.

Read SEC document
January 05, 2021 Filed Jan 7, 2021 01:07 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 5,615 $43.11 $242,062.65
Disclosure

SEC source: 0001209191-21-002386 · doc4.xml · nonDerivative · entry 4

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 20,010

F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 12, 2020.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.97 to $43.41 inclusive.

F3 · ownership.nature: The reportable securities are held directly by the David J. Schlanger 2020 SD LLC.

Read SEC document
January 05, 2021 Filed Jan 7, 2021 01:07 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 34,385 $42.49 $1,461,018.65
Disclosure

SEC source: 0001209191-21-002386 · doc4.xml · nonDerivative · entry 3

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 25,625

F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 12, 2020.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.96 to $42.94 inclusive.

F3 · ownership.nature: The reportable securities are held directly by the David J. Schlanger 2020 SD LLC.

Read SEC document
January 04, 2021 Filed Jan 7, 2021 01:07 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 23,198 $42.80 $992,874.40
Disclosure

SEC source: 0001209191-21-002386 · doc4.xml · nonDerivative · entry 2

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 60,010

F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 12, 2020.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.42 to $43.24 inclusive.

F3 · ownership.nature: The reportable securities are held directly by the David J. Schlanger 2020 SD LLC.

Read SEC document
January 04, 2021 Filed Jan 7, 2021 01:07 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 16,802 $42.01 $705,852.02
Disclosure

SEC source: 0001209191-21-002386 · doc4.xml · nonDerivative · entry 1

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 83,208

F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 12, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.40 to $42.39 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), (6), (7) and (8).

F3 · ownership.nature: The reportable securities are held directly by the David J. Schlanger 2020 SD LLC.

Read SEC document
December 03, 2020 Filed Dec 4, 2020 01:05 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 1,530 $37.84 $57,895.20
Disclosure

SEC source: 0001209191-20-061697 · doc4.xml · nonDerivative · entry 6

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 100,010

F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 12, 2020.

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.71 to $38.04 inclusive.

F3 · ownership.nature: The reportable securities are held directly by the David J. Schlanger 2020 SD LLC.

Read SEC document
December 03, 2020 Filed Dec 4, 2020 01:05 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 38,470 $37.09 $1,426,852.30
Disclosure

SEC source: 0001209191-20-061697 · doc4.xml · nonDerivative · entry 5

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 101,540

F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 12, 2020.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.71 to $37.69 inclusive.

F3 · ownership.nature: The reportable securities are held directly by the David J. Schlanger 2020 SD LLC.

Read SEC document
December 02, 2020 Filed Dec 4, 2020 01:05 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 24,859 $36.48 $906,856.32
Disclosure

SEC source: 0001209191-20-061697 · doc4.xml · nonDerivative · entry 4

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 140,010

F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 12, 2020.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.21 to $37.00 inclusive.

F3 · ownership.nature: The reportable securities are held directly by the David J. Schlanger 2020 SD LLC.

Read SEC document
December 02, 2020 Filed Dec 4, 2020 01:05 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 15,141 $35.90 $543,561.90
Disclosure

SEC source: 0001209191-20-061697 · doc4.xml · nonDerivative · entry 3

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 164,869

F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 12, 2020.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.21 to $36.20 inclusive.

F3 · ownership.nature: The reportable securities are held directly by the David J. Schlanger 2020 SD LLC.

Read SEC document
December 01, 2020 Filed Dec 4, 2020 01:05 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 31,462 $35.68 $1,122,564.16
Disclosure

SEC source: 0001209191-20-061697 · doc4.xml · nonDerivative · entry 2

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 180,010

F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 12, 2020.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.14 to $36.13 inclusive.

F3 · ownership.nature: The reportable securities are held directly by the David J. Schlanger 2020 SD LLC.

Read SEC document
December 01, 2020 Filed Dec 4, 2020 01:05 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 8,538 $34.83 $297,378.54
Disclosure

SEC source: 0001209191-20-061697 · doc4.xml · nonDerivative · entry 1

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 211,472

F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 12, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.13 to $35.11 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), (6), (7) and (8).

F3 · ownership.nature: The reportable securities are held directly by the David J. Schlanger 2020 SD LLC.

Read SEC document
November 11, 2020 Filed Nov 12, 2020 22:08 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 36,940 $29.38 $1,085,297.20
Disclosure

SEC source: 0001209191-20-058040 · doc4.xml · nonDerivative · entry 3

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 220,010

F3 · kind: The reportable securities are held directly by the David J. Schlanger 2020 SD LLC.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.85 to $29.81 inclusive.

F3 · ownership.nature: The reportable securities are held directly by the David J. Schlanger 2020 SD LLC.

Read SEC document
November 10, 2020 Filed Nov 12, 2020 22:08 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 10,862 $29.37 $319,016.94
Disclosure

SEC source: 0001209191-20-058040 · doc4.xml · nonDerivative · entry 2

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 256,950

F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 12, 2020.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.22 to $29.59 inclusive.

F3 · ownership.nature: The reportable securities are held directly by the David J. Schlanger 2020 SD LLC.

Read SEC document
November 10, 2020 Filed Nov 12, 2020 22:08 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 29,138 $28.82 $839,757.16
Disclosure

SEC source: 0001209191-20-058040 · doc4.xml · nonDerivative · entry 1

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 267,812

F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 12, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.22 to $29.21 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4) and (5).

F3 · ownership.nature: The reportable securities are held directly by the David J. Schlanger 2020 SD LLC.

Read SEC document
November 09, 2020 Filed Nov 10, 2020 00:28 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 7,225 $29.80 $215,305.00
Disclosure

SEC source: 0001209191-20-057507 · doc4.xml · nonDerivative · entry 4

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 296,950

F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 12, 2020.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.61 to $30.13 inclusive.

F2 · ownership.nature: The reportable securities are held directly by the David J. Schlanger 2020 SD LLC.

Read SEC document
November 09, 2020 Filed Nov 10, 2020 00:28 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 32,775 $29.19 $956,702.25
Disclosure

SEC source: 0001209191-20-057507 · doc4.xml · nonDerivative · entry 3

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 304,175

F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 12, 2020.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.605 to $29.60 inclusive.

F2 · ownership.nature: The reportable securities are held directly by the David J. Schlanger 2020 SD LLC.

Read SEC document
November 06, 2020 Filed Nov 10, 2020 00:28 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 2,560 $27.97 $71,603.20
Disclosure

SEC source: 0001209191-20-057507 · doc4.xml · nonDerivative · entry 2

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 336,950

F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 12, 2020.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.73 to $28.08 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote2 (3), (4) and (5).

F2 · ownership.nature: The reportable securities are held directly by the David J. Schlanger 2020 SD LLC.

Read SEC document
November 05, 2020 Filed Nov 10, 2020 00:28 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 500 $27.65 $13,825.00
Disclosure

SEC source: 0001209191-20-057507 · doc4.xml · nonDerivative · entry 1

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 339,510

F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 12, 2020.

F2 · ownership.nature: The reportable securities are held directly by the David J. Schlanger 2020 SD LLC.

Read SEC document
October 05, 2020 Filed Oct 5, 2020 23:19 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 1,945 $29.81 $57,980.45
Disclosure

SEC source: 0001209191-20-053894 · doc4.xml · nonDerivative · entry 6

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 340,010

F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 12, 2020.

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.80 to $29.84 inclusive.

F3 · ownership.nature: The reportable securities are held directly by the David J. Schlanger 2020 SD LLC.

Read SEC document
October 05, 2020 Filed Oct 5, 2020 23:19 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 38,055 $29.41 $1,119,197.55
Disclosure

SEC source: 0001209191-20-053894 · doc4.xml · nonDerivative · entry 5

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 341,955

F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 12, 2020.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.80 to $29.78 inclusive.

F3 · ownership.nature: The reportable securities are held directly by the David J. Schlanger 2020 SD LLC.

Read SEC document
October 02, 2020 Filed Oct 5, 2020 23:19 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 300 $29.18 $8,754.00
Disclosure

SEC source: 0001209191-20-053894 · doc4.xml · nonDerivative · entry 4

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 380,010

F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 12, 2020.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.15 to $29.23 inclusive.

F3 · ownership.nature: The reportable securities are held directly by the David J. Schlanger 2020 SD LLC.

Read SEC document
October 02, 2020 Filed Oct 5, 2020 23:19 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 39,700 $28.54 $1,133,038.00
Disclosure

SEC source: 0001209191-20-053894 · doc4.xml · nonDerivative · entry 3

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 380,310

F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 12, 2020.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.10 to $29.05 inclusive.

F3 · ownership.nature: The reportable securities are held directly by the David J. Schlanger 2020 SD LLC.

Read SEC document
October 01, 2020 Filed Oct 5, 2020 23:19 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 4,965 $29.37 $145,822.05
Disclosure

SEC source: 0001209191-20-053894 · doc4.xml · nonDerivative · entry 2

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 420,010

F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 12, 2020.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.22 to $29.89 inclusive.

F3 · ownership.nature: The reportable securities are held directly by the David J. Schlanger 2020 SD LLC.

Read SEC document
October 01, 2020 Filed Oct 5, 2020 23:19 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 35,035 $28.64 $1,003,402.40
Disclosure

SEC source: 0001209191-20-053894 · doc4.xml · nonDerivative · entry 1

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 424,975

F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 12, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.22 to $29.20 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), (6), (7) and (8) herein.

F3 · ownership.nature: The reportable securities are held directly by the David J. Schlanger 2020 SD LLC.

Read SEC document
September 29, 2020 Filed Sep 30, 2020 00:07 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 3,324 $29.51 $98,091.24
Disclosure

SEC source: 0001209191-20-052401 · doc4.xml · nonDerivative · entry 4

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 460,010

F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 12, 2020.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.40 to $29.73 inclusive.

F3 · ownership.nature: The reportable securities are held directly by the David J. Schlanger 2020 SD LLC.

Read SEC document
September 29, 2020 Filed Sep 30, 2020 00:07 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 8,131 $29.00 $235,799.00
Disclosure

SEC source: 0001209191-20-052401 · doc4.xml · nonDerivative · entry 3

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 463,334

F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 12, 2020.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.40 to $29.39 inclusive.

F3 · ownership.nature: The reportable securities are held directly by the David J. Schlanger 2020 SD LLC.

Read SEC document
September 28, 2020 Filed Sep 30, 2020 00:07 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 26,331 $28.54 $751,486.74
Disclosure

SEC source: 0001209191-20-052401 · doc4.xml · nonDerivative · entry 2

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 471,465

F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 12, 2020.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.28 to $29.19 inclusive.

F3 · ownership.nature: The reportable securities are held directly by the David J. Schlanger 2020 SD LLC.

Read SEC document
September 25, 2020 Filed Sep 30, 2020 00:07 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 40,000 $28.40 $1,136,000.00
Disclosure

SEC source: 0001209191-20-052401 · doc4.xml · nonDerivative · entry 1

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 497,796

F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 12, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.30 to $28.73 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5) and (6).

F3 · ownership.nature: The reportable securities are held directly by the David J. Schlanger 2020 SD LLC.

Read SEC document
September 16, 2020 Filed Sep 18, 2020 00:34 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 40,000 $28.80 $1,152,000.00
Disclosure

SEC source: 0001209191-20-051064 · doc4.xml · nonDerivative · entry 4

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 537,796

F3 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 12, 2020.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.58 to $29.09 inclusive.

F2 · ownership.nature: The reportable securities are held directly by the LLC.

Read SEC document
September 15, 2020 Filed Sep 18, 2020 00:34 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 2,214 $28.58 $63,276.12
Disclosure

SEC source: 0001209191-20-051064 · doc4.xml · nonDerivative · entry 3

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 577,796

F3 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 12, 2020.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.56 to $28.605 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4) and (5).

F2 · ownership.nature: The reportable securities are held directly by the LLC.

Read SEC document
September 04, 2020 Filed Sep 18, 2020 00:34 UTC Progyny, Inc. PGNY · Entity 4521 GiftCommon Stock 580,010 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-051064 · doc4.xml · nonDerivative · entry 2

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 580,010

F1 · kind: On September 4, 2020, the Reporting Person gifted 580,010 shares of common stock to David J. Schlanger 2020 SD LLC (the "LLC").

F2 · ownership.nature: The reportable securities are held directly by the LLC.

Read SEC document
September 04, 2020 Filed Sep 18, 2020 00:34 UTC Progyny, Inc. PGNY · Entity 4521 GiftCommon Stock 580,010 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-051064 · doc4.xml · nonDerivative · entry 1

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: On September 4, 2020, the Reporting Person gifted 580,010 shares of common stock to David J. Schlanger 2020 SD LLC (the "LLC").

Read SEC document
August 10, 2020 Filed Aug 10, 2020 23:28 UTC Progyny, Inc. PGNY · Entity 4521 Exercise / conversionEmployee Stock Option (right to buy) · Derivative 46,521 $0.00 Strike: $0.91 $0.00
Disclosure

SEC source: 0001209191-20-046019 · doc4.xml · derivative · entry 10

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,734,384

Underlying: Common Stock · 46,521 shares

Expires 2027-08-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on January 16, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.

Read SEC document
August 10, 2020 Filed Aug 10, 2020 23:28 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 46,521 $27.72 $1,289,562.12
Disclosure

SEC source: 0001209191-20-046019 · doc4.xml · nonDerivative · entry 6

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 580,010

F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 12, 2020.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.52 to $27.97 inclusive.

Read SEC document
August 10, 2020 Filed Aug 10, 2020 23:28 UTC Progyny, Inc. PGNY · Entity 4521 Exercise / conversionCommon Stock 46,521 $0.91 $42,334.11
Disclosure

SEC source: 0001209191-20-046019 · doc4.xml · nonDerivative · entry 5

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 626,531

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 07, 2020 Filed Aug 10, 2020 23:28 UTC Progyny, Inc. PGNY · Entity 4521 Exercise / conversionEmployee Stock Option (right to buy) · Derivative 1,000 $0.00 Strike: $0.91 $0.00
Disclosure

SEC source: 0001209191-20-046019 · doc4.xml · derivative · entry 9

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,780,905

Underlying: Common Stock · 1,000 shares

Expires 2027-08-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on January 16, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.

Read SEC document
August 07, 2020 Filed Aug 10, 2020 23:28 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 1,000 $27.49 $27,490.00
Disclosure

SEC source: 0001209191-20-046019 · doc4.xml · nonDerivative · entry 4

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 580,010

F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 12, 2020.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.48 to $27.50 inclusive.

Read SEC document
August 07, 2020 Filed Aug 10, 2020 23:28 UTC Progyny, Inc. PGNY · Entity 4521 Exercise / conversionCommon Stock 1,000 $0.91 $910.00
Disclosure

SEC source: 0001209191-20-046019 · doc4.xml · nonDerivative · entry 3

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 581,010

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 06, 2020 Filed Aug 10, 2020 23:28 UTC Progyny, Inc. PGNY · Entity 4521 Exercise / conversionEmployee Stock Option (right to buy) · Derivative 12,479 $0.00 Strike: $0.91 $0.00
Disclosure

SEC source: 0001209191-20-046019 · doc4.xml · derivative · entry 8

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,781,905

Underlying: Common Stock · 12,479 shares

Expires 2027-08-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on January 16, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.

Read SEC document
August 06, 2020 Filed Aug 10, 2020 23:28 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 12,479 $27.45 $342,548.55
Disclosure

SEC source: 0001209191-20-046019 · doc4.xml · nonDerivative · entry 2

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 580,010

F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 12, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.42 to $27.56 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4).

Read SEC document
August 06, 2020 Filed Aug 10, 2020 23:28 UTC Progyny, Inc. PGNY · Entity 4521 Exercise / conversionCommon Stock 12,479 $0.91 $11,355.89
Disclosure

SEC source: 0001209191-20-046019 · doc4.xml · nonDerivative · entry 1

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 592,489

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 05, 2020 Filed Aug 6, 2020 00:53 UTC Progyny, Inc. PGNY · Entity 4521 Exercise / conversionEmployee Stock Option (right to buy) · Derivative 39,896 $0.00 Strike: $0.91 $0.00
Disclosure

SEC source: 0001209191-20-045391 · doc4.xml · derivative · entry 10

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,794,384

Underlying: Common Stock · 39,896 shares

Expires 2027-08-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on January 16, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.

Read SEC document
August 05, 2020 Filed Aug 6, 2020 00:53 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 39,896 $27.40 $1,093,150.40
Disclosure

SEC source: 0001209191-20-045391 · doc4.xml · nonDerivative · entry 6

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 580,010

F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 12, 2020.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.34 to $27.61 inclusive.

Read SEC document
August 05, 2020 Filed Aug 6, 2020 00:53 UTC Progyny, Inc. PGNY · Entity 4521 Exercise / conversionCommon Stock 39,896 $0.91 $36,305.36
Disclosure

SEC source: 0001209191-20-045391 · doc4.xml · nonDerivative · entry 5

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 619,906

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 04, 2020 Filed Aug 6, 2020 00:53 UTC Progyny, Inc. PGNY · Entity 4521 Exercise / conversionEmployee Stock Option (right to buy) · Derivative 104 $0.00 Strike: $0.91 $0.00
Disclosure

SEC source: 0001209191-20-045391 · doc4.xml · derivative · entry 9

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,834,280

Underlying: Common Stock · 104 shares

Expires 2027-08-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on January 16, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.